Patterns, costs and cost-effectiveness of care in a trial of chemotherapy for advanced non-small cell lung cancer
- 31 August 2002
- journal article
- clinical trial
- Published by Elsevier BV in Lung Cancer
- Vol. 37 (2), 219-225
- https://doi.org/10.1016/s0169-5002(02)00042-9
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Analysis of cost data in randomized trials: an application of the non-parametric bootstrapStatistics in Medicine, 2000
- Decision framework for chemotherapeutic interventions for metastatic non-small-cell lung cancer.JNCI Journal of the National Cancer Institute, 2000
- Mitomycin, Ifosfamide, and Cisplatin in Unresectable Non–Small-Cell Lung Cancer: Effects on Survival and Quality of LifeJournal of Clinical Oncology, 1999
- The hospital costs of treating lung cancer in the United KingdomBritish Journal of Cancer, 1999
- The cost-effectiveness of navelbine alone or in combination with cisplatin in comparison to other chemotherapy regimens and best supportive care in stage IV non-small cell lung cancerEuropean Journal of Cancer, 1996
- Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trialsBMJ, 1995
- Counting the costs of chemotherapy in a National Cancer Institute of Canada randomized trial in nonsmall-cell lung cancer.Journal of Clinical Oncology, 1990
- A cost-effectiveness analysis of the treatment of chronic renal failureApplied Economics, 1981